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ABSTRACT: 
Objective: The aim of this study was to investigate the anti-obesity effects of the polyphenol 
fisetin in 3T3-L1 preadipocytes and C57BL/6 female mice that were fed a high-fat diet (HFD). 
 
Background:  Polyphenols,  such  as  sakuranetin,  hesperetin,  tea  catechin,  and  quercetin, 
reportedly regulate adipocyte differentiation in 3T3-L1 cells.    Furthermore, green tea, apple, 
and molokheiya polyphenols exhibit anti-obesity activities in HFD-treated obese rats or mice. 
Fisetin is abundant in plants, fruits, and vegetables and exhibits multiple biological activities, 
such  as  the  inhibition  of  prostate  cancer  growth,  neuroprotection,  and  protection  against 
osteoporosis.    In addition, fisetin regulates obesity by targeting mammalian target of rapamycin 
complex 1 signaling, which is a central mediator of lipid biosynthesis. 
 
Materials  and  methods:  (1)  in  vitro  experiments;  we  investigated  the  effects  of  fisetin  on 
intracellular lipid accumulation and glycerol-3-phosphate activity during the differentiation of 
3T3-L1  cells.    We  monitored  expression  of  adipogenetic  related-genes  in  3T3-L1  cells  by 
real-time  polymerase-chain-reaction.    (2)  in  vivo  experiments;  we  examined  the  effects  of 
fisetin on anti-obesity activities in C57BL/6 female mice that were fed a HFD. 
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Results:  Fisetin  inhibited  intracellular  lipid  accumulation  and  glycerol-3-phosphate  activity 
during the differentiation of 3T3-L1 cells in a dose-dependent manner (50-75 M). In addition, 
real-time polymerase-chain-reaction revealed that this compound suppressed the expression of 
peroxisome proliferator-activated receptor γ (PPARγ), adipocyte protein 2, and perilipin mRNAs 
in 3T3-L1 cells.    In contrast, anti-obesity activities, such as reduction of body weight and fat 
tissue, and improvements in obesity-related blood biochemical parameters and fatty liver, were 
not  observed  in  HFD-induced  mice  treated  with  fisetin  (20  mg/kg  body  weight)  by 
intraperitoneal injections twice per week for 8 weeks.
 
Conclusions: Fisetin exerted anti-adipogenic activities by inhibiting the expression of PPARγ 
mRNA  in  3T3-L1  preadipocytes.    However,  fisetin  (20  mg/kg  body  weight)  did  not  affect 
HFD-induced obesity.    Our findings indicated that fisetin could be used as an effective remedy 
in the treatment of the symptoms of obesity. 
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INTRODUCTION: 
Obesity and related metabolic diseases such as type-2 diabetes, atherosclerosis, hypertension, 
and fatty liver, are the  most prevalent nutrition-related issues  in  the  world.    The control  of 
adipocyte differentiation and proliferation could be a strategy for the prevention and treatment of 
obesity and related metabolic diseases.    The differentiation of preadipocyte into adipocyte is 
controlled by a complex network of a variety of proteins.    For example, it has been shown that 
peroxisome  proliferator-activated  receptor  γ  (PPAR)  plays  critical  roles  in  adipocyte 
differentiation  [1,  2].    Increased  oxidative  stress  in  accumulated  fat  is  an  early  cause  of 
metabolic syndrome and the redox state in adipose tissue is a potentially useful therapeutic target 
for  obesity  related  metabolic  diseases  [3].    Polyphenols  display  anti-oxidant  and 
anti-inflammatory properties.    Recent reports have stated that sakuranetin [4], hesperetin [5, 6], 
and  naringenin  [6]  induce  adipogenesis  in  3T3-L1  cells.    In  contrast,  quercetin  [7]  and 
epigallocatechin  gallate  [8]  exhibit  anti-obesity  activities  in  3T3-L1  preadipocytes.   
Kaempferitrin also inhibits glucose transporter 4 translocation and glucose uptake in 3T3-L1 
adipocytes [9].    Furthermore, green tea [10], apple [11], and molokheiya [12] polyphenols show 
anti-obesity activities in high-fat diet (HFD)-treated obese rats or mice. Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 431 of 441 
Fisetin (3,7,3’,4’-tetrahydroxyflavone) is a polyphenol that is abundant in plants, fruits, and 
vegetables  and  exhibits  multiple  biological  activities,  such  as  inhibition  of  prostate  cancer 
growth [13], prevention of rheumatoid arthritis [14], and protection against osteoporosis [15].  
Furthermore, fisetin promotes ERK-dependent long-term potentiation in rat hippocampal slices 
and enhances memory in mice [16].    Fisetin is also known to act via the activation of the Nrf2 
pathway  [17],  which  is  the  major  regulator  of  cytoprotective  responses  to  oxidative  and 
electrophilic stress.  Recently, it has been reported that fisetin regulates obesity by targeting 
mammalian  target  of  rapamycin  complex  1  signaling,  which  is  a  central  mediator  of  lipid 
biosynthesis [18]. 
The present study was designed to evaluate the in vitro and in vivo anti-obesity effects of 
fisetin in 3T3-L1 adipocytes and HFD-treated mice.  Our results indicated that fisetin attenuated 
adipogenesis in 3T3-L1 cells by inhibiting the expression of PPAR mRNA. 
 
MATERIALS AND METHODS: 
Materials:  Fisetin was purchased from Tokyo Kasei Co., Ltd. (Tokyo, Japan).    Dulbecco’s 
Modified  Eagle’s  Medium  (DMEM;  High-glucose)  and  penicillin/streptomycin  antibiotic 
mixture  were  obtained  from  Sigma-Aldrich  K.K.  (Tokyo,  Japan)  and  Life  Technologies 
Corporation (Grand Island, NY, USA), respectively.    Fetal bovine serum was obtained from 
JRH Bioscience, Inc. (Lenexa, KS, USA). 
 
Cell  culture:  Mouse preadipocyte 3T3-L1 cells  were  obtained from  the RIKEN Cell Bank 
(Tsukuba, Japan).    Cells were maintained in a 55-cm
2 dish in DMEM, which was supplemented 
with  10%  fetal  bovine  serum,  50  units/mL  penicillin,  and  50  g/mL  streptomycin,  in  a 
humidified atmosphere of 5% CO2 in air at 37 °C.    After reaching 70% confluence, the cells 
were detached by treatment with 0.05% trypsin, replated in either 6-well plates (area of each well, 
9.4 cm
2) or 12-well plates (area of each well, 3.8 cm
2) at a density of 2 × 10
4 cells/cm
2, and 
grown in DMEM, which was supplemented with 10% fetal bovine serum, 50 units/mL penicillin, 
and  50  g/mL  streptomycin.    After  confluence,  the  cells  were  cultured  for  2  days  in  the 
presence of various concentrations of fisetin, and continuously cultured for 2 days with 0.25 M 
of dexamethasone (Sigma-Aldrich K.K.), 0.2 mM 3-iso-butyl-1-methylxanthine (Sigma-Aldrich 
K.K.),  and  10  g/mL  insulin  (Wako  Pure  Chemical  Industries,  Ltd.,  Osaka,  Japan)(DMI 
induction).    The cells were then cultured in medium containing 5 g/mL of insulin. 
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Animal  models:  Female  4-week-old  C57BL/6J  mice  were  obtained  from  CLEA  Japan,  Inc. 
(Tokyo, Japan).    The mice were randomly divided into the following four groups: mice fed the 
Mouse  Feed  (MF;  Oriental  Yeast  Co.  Ltd.,  Tokyo,  Japan)  with  the  administration  of  saline 
(normal group), mice fed the MF with the administration of fisetin [20 mg/kg body weight, twice 
per a week, intraperitoneal (i.p.)] (normal fisetin group), mice fed a HFD (CLEA Rodent Diet 
Quick Fat; CLEA Japan, Inc.) with the administration of saline (HFD group), and mice fed a 
HFD  with  the  administration  of  fisetin  (20  mg/kg  body  weight,  twice  per  a  week,  i.p.) 
(HFD-fisetin group) for 8 weeks.    Body weight was measured weekly.    The care and use of the 
animals followed our institutional and national guidelines, and all of the experimental procedures 
were approved by the animal committee of Toin University of Yokohama. 
 
Computed Tomography (CT) Scan Analysis: The amount of visceral fat and subcutaneous fat in 
the HFD-fed mice were examined by radiography with a CT apparatus (LaTheta LCT-100M, 
Hitachi Aloka Medical, Ltd, Tokyo, Japan), according to the manufacturer’s protocol.    The CT 
scanning was done at 1-mm intervals from the diaphragm to the bottom of the abdominal cavity.   
First, an overview scan of the whole mouse was conducted to allow for the selection of the 
regions of interest for the different scans.    To quantify the visceral and subcutaneous fat depots 
the area between the proximal end of lumbar vertebra L3 and the distal end of L5 was scanned.   
For the liver fat quantification the areas that include liver and spleen (between the cranial part of 
the diaphragm and the lumbar vertebra L3) and adipose tissue (narrow area in the region of the 
lumbosacral joint) were scanned.    Abdominal muscle was used as a discriminant between the 
visceral and subcutaneous fat depots. 
 
Sample preparation and procedures: Eight weeks after supplementation with the experimental 
diets, the mice were sacrificed.    Blood samples were collected from the heart and centrifuged at 
1,000 × g for 10 min, and serum triglyceride (TG), total cholesterol, asparatate aminotransferase 
(AST), and alanine aminotransferase (ALT) levels were measured by BML, Inc. (Tokyo, Japan).   
The liver and kidney were excised and fixed in a 10% neutral-buffered formalin solution and 
processed  for  histology.    The  liver  and  kidney  were  snap-frozen  with  Optimal  Cutting 
Temperature (OCT) compound in liquid nitrogen and stored at -80 °C. 
 
Histological analysis: Fixed tissues were embedded in paraffin, sliced into 4-µm-thick sections 
and  stained  with  hematoxylin  and  eosin.    The  pathological  changes  were  assessed  and Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 433 of 441 
photographed with the All-in-One Fluorescence Microscope system (BZ-8100 and BZ-Analyzer, 
Keyence Corporation, Osaka, Japan).     
 
Oil-red O staining: Cells were cultured in medium containing fisetin (0, 25, 50, or 75 M) for 2 
days.    Frozen liver sections and cells were fixed with 4% paraformaldehyde for 1 h, and then 
stained with 3 mg/mL Oil-red O (in 60% isopropanol) for 10 min.    After washing twice with 
60% isopropanol, images were collected on the All-in-One Fluorescence Microscope system.   
In addition, the dye was eluted for 10 min with 100% isopropanol.    The concentration of the 
eluted dye was determined from measurements of absorbance (Optical Density, 420 nm).   
 
Glycerol-3-phosphate dehydrogenase (GPDH) activity: GPDH activity was measured with a 
GPDH Activity Assay  Kit  (Takara  Bio,  Inc., Tokyo,  Japan)  according  to  the manufacturer’s 
instructions.    One  unit  was  defined  as  the  amount  of  enzyme  that  was  required  for  the 
consumption of 1 μmol of nicotinamide adenine dinucleotide in 1 min at 30 °C.    Each assay 
was conducted in duplicate. 
 
Real-time  polymerase-chain-reaction  (PCR):  The  mRNA  levels  of  expression  of  PPARγ, 
adipocyte protein 2 (aP2), and perilipin in 3T3-L1 cells were examined by real-time PCR.    The 
RNeasy Mini Kit (Qiagen K.K., Tokyo, Japan) was used to extract RNA from the cells that had 
been exposed to various concentrations of fisetin for 2 days after confluence.    Total RNA (1 g) 
was  reverse  transcribed  with  the  Transcriptor  First  Strand  cDNA  Synthesis  Kit  (Roche 
Diagnostics K.K., Tokyo, Japan) with random primers in a 20-L reaction mixture according to 
the manufacturer’s protocol.    The quantitative PCR analysis was performed with a LightCycler 
480 System II (Roche Diagnostics K.K.) and LightCycler 480 SYBR Green I Master (Roche 
Diagnostics K.K.).    The PCR (95 °C for 10 s, 55 °C for 10 s, and 72 °C for 10 s, for 45 cycles) 
was performed with specific primers (sense primer, 5’- GATGCACTGCCTATGAGCACTT- 3’, 
and antisense primer, 5’- AGAGGTCCACAGAGCTGATTCC- 3’) for mouse PPARγ, (sense 
primer,  5’-  CCGCAGACGACAGGAAGGT  -3’,  and  antisense  primer,  5’- 
AGGGCCCCGCCATCT  -3’)  for  mouse  aP2,  (sense  primer,  5’- 
CTCTGGGAAGCATCGAGAAG  -3’,  and  antisense  primer,  5’- 
GCATGGTGTGTCGAGAAAGA  -3’)  for  mouse  perilipin,  (sense  primer,  5’- 
TGGGCATCACCACGAAAAT  -3’,  and  antisense  primer,  5’- 
ATCAGCTGCACATCACTCAGAATT  -3’)  for  mouse  36B4,  and  (sense  primer,  5’- Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 434 of 441 
TTCTACAATGAGCTGCGTGTG  -3’,  and  antisense  primer,  5’- 
GGGGTGTTGAAGGTCTCAAA  -3’)  for  mouse  ACTB.    36B4  (for  PPARγ  and  aP2)  and 
ACTB (for perilipin) were used as internal standards for the normalization of each sample. 
 
Statistical Analysis: The data are expressed as mean ± standard deviation (SD).    The statistical 
analysis was performed with Student’s t-tests to compare the group means with and without 
fisetin  administration.    Two-tailed  P-values  less  than  0.05  were  considered  statistically 
significant.   
 
RESULTS: 
Effects  of  fisetin  on  the  adipogenetic  differentiation  of  3T3-L1  preadipocytes:  During  the 
differentiation  of  3T3-L1  cells,  the  cells  were  treated  with  fisetin  at  25  to  75  M,  and 
intracellular oil droplets were stained with Oil-red O and quantified.    Fisetin at 50 M and 75 
M  significantly  suppressed  lipid  accumulation,  and  75  M  of  fisetininhibited  it  to   
compared to dimethyl sulfoxide (DMSO)-treated control cells (Figs. 1A and 1B). Furthermore, 
to examine the suppressive effects of fisetin on differentiation, GPDH activity was measured in 
3T3-L1 cells that were treated with fisetin (Fig. 1C).    GPDH activity was completely inhibited 
by 75 M of fisetin. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.    Fisetin suppressed intracellular lipid accumulation and GPDH activity in 3T3-L1 cells during 
differentiation.    The  cells  were  differentiated  to  adipocytes  as  described  in  the  Materials  and  Methods 
section.    During differentiation, 25 µM, 50 µM, 75 µM, or DMSO, which was used as a vehicle control, was 
added to the medium.    (A) The cells were stained with Oil-red O. Bars = 100 µm.    (B) Intracellular lipid 
accumulation was determined by Oil-red O.    The values are expressed as the mean ± SD of 3 independent 
experiments.    (C) Intracellular GPDH activity was measured.    The values were calculated as a ratio of the 
vehicle and expressed as the mean ± S.D. of 3 independent experiments.  *P < 0.05 vs. vehicle. Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 435 of 441 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To  investigate  the  inhibitory  mechanisms  of  fisetin  during  adipocyte  differentiation,  we 
examined the expression of PPARγ, which acts as a key transcription factor at an early stage of 
adipocyte differentiation, and the expression of aP2 and perilipin, both of which are expressed 
down-stream  of  PPARγ.    Real-time  PCR  revealed  that  fisetin  suppressed  the  expression  of 
PPARγ, aP2, and perilipin mRNAs in 3T3-L1 cells in a dose dependent-manner (25 to 75 M), 
as shown in Figs. 2A, 2B, and 2C, respectively. 
 
Effects  of  fisetin  on  HFD-induced  obesity:  We  examined  the  effects  of  fisetin  on  body  weight  in 
C57BL/6 female mice that were fed a control diet or HFD for 8 weeks.    Fisetin (20 mg/kg body weight) 
was intraperitoneally injected into the mice of each group twice per week.    Twenty mg/kg body weight 
of fisetin did not affect the body weights of normal diet (ND) mice, but significantly increased the body 
weights of HFD-treated mice (Fig. 3A).    Figure 3B shows typical CT images that were obtained with the   
Figure 2.    Fisetin suppressed the expression of PPARγ, aP2, and perilipin.    The cells were differentiated to 
adipocytes as described in the Materials and Methods section.    During differentiation, 25 µM, 50 µM, 75 µM, 
or  DMSO  (vehicle  control)  was  added  to  the  medium.    The  mRNA  levels  of  PPARγ  (A),  aP2  (B),  and 
perilipin (C) were determined by real-time PCR analysis.    The values were calculated as a ratio of the vehicle 
and expressed as the mean ± S.D. of 3 independent experiments.  *P < 0.05 vs. vehicle, **P < 0.01 vs. vehicle. Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 436 of 441 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LA Theta LCT-100 from the abdomen for the detection of fat tissue.    Furthermore, the amounts of body 
fat (Fig. 3C), abdominal adipose tissue (Fig. 3D), subcutaneous adipose tissue (Fig. 3E), and muscle (Fig. 
3F) were calculated for each group.    Fisetin did not affect the fat tissues or muscle in both groups of 
mice fed a ND or HFD. 
Figure 3.    Fisetin did not show antiobesity activity in HFD-treated obese mice.    Mice (n = 4 or 5 per group) 
were treated with fisetin (20 mg/kg body weight) by intraperitoneal injections twice per week for 8 weeks.   
(A) The body weights of the mice were measured.    (B) Typical images of X-ray computed tomography of the 
mice abdomens for the detection of fat tissue.    The detected tissue was assessed for body fat (C), abdominal 
adipose tissue (D), subcutaneous adipose tissue (E), and muscle (F).  *P < 0.05 vs. HFD saline.   
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Next, we monitored the levels of TG (Fig. 4A), total cholesterol (Fig. 4B), AST (Fig. 4C), 
and ALT (Fig. 4D) in the blood samples at the end of the 8 weeks of the HFD.    Fisetin did not 
improve the obesity-related blood biochemical parameters in the HFD-treated obesity group. 
As shown in Figure 5, the HFD-treated obese mice had fatty livers (Oil-red O stain), but 
fisetin did not suppress the fatty livers in the HFD-treated obese mice.    Fisetin did not affect the 
kidneys of ND and HFD-treated obese mice. 
Figure 4.    Fisetin did not improve obesity-related blood biochemical parameters.    Blood samples from 
the mice were measured by BML, Inc.    The levels of TG (A), total cholesterol (B), AST (C), and ALT 
(D) are expressed as the mean ± SD. Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 438 of 441 
 
 
 
 
DISCUSSION: 
In this study, we attempted to clarify the potential effects of the polyphenol fisetin on obesity, 
and found that fisetin attenuated adipocyte differentiation (intracellular lipid accumulation and 
GPDH  activity)  through  the  inhibition  of  the  expression  of  PPARγ  mRNA  during  the 
differentiation of 3T3-L1 preadipocytes.    Furthermore, the injection of fisetin at a dose of 20 
mg/kg body weight into HFD-treated obese mice for 8 weeks increased the body weight, but it 
did not show anti-obesity effects on HFD-induced obesity.    The effect of fisetin on weight gain 
in mice fed a HFD is interesting, although the underlying mechanism is unclear. 
C57BL/6  male  mice  have  been  used  to  study  HFD-induced  obesity  [19-22].    Recently, 
gender differences in weight gain have been studied in angiotensin receptor- [23], Nur77- [24], 
and lecithin cholesterol acyltransferase- (25) knockout mice with HFD-induced obesity.    We 
used C57BL/6 female mice in this study because we attempted to investigate the effects of fisetin 
Figure 5.    Fisetin did not suppress fatty liver in the HFD-treated obese mice.    Liver tissues from 
the mice were analyzed histochemically with hematoxylin-eosin (HE) stain and Oil-red O stain.   
Kidney tissues from the mice were also analyzed with HE stain.  Bars = 50µm. Functional Foods in Health and Disease 2014; 4(10):429-441                                         Page 439 of 441 
on alterations in abdominal adipose tissue in female mice in which it is difficult to accumulate 
abdominal adipose tissue compared to subcutaneous adipose tissue.    CT scanning revealed that 
fisetin at 20 mg/kg body weight did not affect the fat tissues containing abdominal adipose tissue 
in both groups of mice fed ND and HFD. 
Fisetin  at  25  to  75  M  inhibited  the  expression  of  PPARγ  mRNA,  which  is  a  key 
transcription factor at an early stage of adipocyte differentiation, in 3T3-L1 cells.    However, the 
injection  of  20  mg/kg  body  weight  fisetin  into  HFD-treated  mice  did  not  show  anti-obesity 
effects.    Recently,  it  was  reported  that  daily  fisetin  supplementation  displayed 
hypocholesterolemic effects in HFD Sprague-Dawley rats [26].    Future studies on high-dose 
fisetin in HFD-treated obese mice may aid the prevention of obesity.  We also hypothesized 
from our results that fisetin may decompose in the body.    Fisetin may be used as an effective 
remedy in the treatment of the symptoms of obesity if we are able to elucidate the mechanisms 
by which fisetin specifically acts upon PPARγ expression in adipocytes. 
 
CONCLUSIONS:  Our  results  suggested  that  the  inhibition  of  PPARγ  signaling  by  fisetin 
inhbited the adipocyte differentiation of 3T3-L1 preadipocytes.    However, fisetin at 20 mg/kg 
body  weight  did  not  affect  HFD-induced  obesity.    These  findings  provide  insights  into  the 
development of tools for the prevention and treatment of obesity.     
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